RESUMEN
Background: The National Action Plan on Antimicrobial Resistance in Bhutan promotes the rational use of antibiotics. It is important to establish baseline data on the use of antibiotics and the quality indicators of antibiotic prescriptions to identify where improvement efforts may need to be focused. Objectives: To describe the prevalence and patterns of antibiotic prescription and establish baseline data regarding quality indicators of antibiotic prescriptions in four major hospitals in Bhutan. Methods: This was a point prevalence survey of antibiotic use among inpatients in June 2022 conducted using the Australian National Antibiotic Prescribing Survey (NAPS). Results: There were 314 patients (41.5%) receiving at least one antibiotic on the audit day. Among prescriptions reviewed, 278 (88.5%) had indications for use documented, 102 (32.5%) had a review or stop date documented and 120 (38.2%) had microbiology samples collected prior to antibiotics. Ceftriaxone (68; 21.7%), cefazolin (41; 13.1%) and metronidazole (32; 10.2%), were the common antibiotics prescribed. The most common indications for use were surgical prophylaxis (42; 13.4%), community-acquired pneumonia (39; 12.4%) and sepsis (26; 8.3%). There were 125 prescriptions (39.8%) that were compliant with national/therapeutic antibiotic guidelines and 169 (53.8%) where antibiotic prescriptions were appropriate. Conclusions: This study identified key areas for targeted interventions in antimicrobial stewardship programmes in Bhutan. The prevalence of antibiotic use, indications for use, and drug choices were similar to data from other countries. Documentation plans for durations of use, prolonged surgical prophylaxis and concordance of choices with guideline recommendations present opportunities for improvement.
RESUMEN
The novel coronavirus 2019 (COVID-19) which is caused by severe acute respiratory syndrome coronavirus-2 was first reported from Wuhan, China in December 2019. Since then, it has caused global crisis and it still continues to be a Public Health Emergency of International Concern. Although it primarily involves respiratory system with symptoms ranging from mild to severe acute respiratory distress syndrome, extrapulmonary involvement including gastrointestinal manifestations is increasingly reported. There are few reported cases of acute pancreatitis following severe acute respiratory syndrome coronavirus-2 infection; however, little is known on true prevalence of acute pancreatitis or other extrapulmonary manifestations. More data and research on pathophysiology and organ-specific extrapulmonary manifestations would aid clinicians to monitor and recognise these wide spectra of manifestations so that organ-specific therapeutic strategies and management pathways could be developed. We report a case of acute pancreatitis in an otherwise asymptomatic severe acute respiratory syndrome coronavirus-2 infection. He developed acute upper abdominal pain on day 13th of severe acute respiratory syndrome coronavirus-2 infection detection. Diagnosis of acute pancreatitis was made after his serum amylase level was raised by more than five times the normal and the computed tomography abdomen showed oedematous pancreas. He was successfully managed and discharged after 12 days of diagnosis of acute pancreatitis. On follow-up after 1 year, there were no recurrent attacks of pancreatitis. Our case highlights that acute pancreatitis can occur even in asymptomatic and milder form of COVID-19 and the onset of such complications could be delayed. Abdominal pain in COVID-19 should be carefully assessed because prompt diagnosis and management of acute pancreatitis in COVID-19 patient is crucial in preventing multi-organ dysfunction leading to subsequent morbidity and mortality.
RESUMEN
Anti-phospholipid syndrome is an autoimmune disorder characterized by episodes of arterial and/or venous thrombosis and/or pregnancy morbidity in the presence of anti-phospholipid antibodies. Catastrophic anti-phospholipid syndrome is an accelerated form of the disease with rapid involvement of multiple organ systems often posing a diagnostic challenge. There is a paucity of literature on the myriad presentations of catastrophic anti-phospholipid syndrome owing to the orphan nature of the disease. We present three cases of catastrophic anti-phospholipid syndrome in patients with systemic lupus erythematosus that presented with episodes of thrombosis involving both arterial and venous systems and multisystem organ failure. Timely diagnoses were made based on a high index of suspicion and were managed with a combination of systemic glucocorticoids, cyclophosphamide, plasmapheresis, intravenous immunoglobulin and other supportive measures. However, despite providing the standard of care, we encountered a poor outcome in two of these patients, highlighting the high mortality associated with catastrophic anti-phospholipid syndrome.
RESUMEN
Developing nations face the double burden of communicable and noncommunicable diseases. Bhutan is a developing country and has achieved significant milestones in its health indicators. Increasing burden of stroke and the lack of evidence-based stroke care system in the country's hospitals are proving to be a challenge to provide quality stroke care. Despite the logistical challenge of referring stroke patients on time, lack of trained health care professionals and resources, Bhutan has recently started various initiatives to improve stroke care with the help of WHO-SEARO, WHO-Geneva, and Christian Medical College, Ludhiana, India.